Global Plant Tissue Culture Market to Generate $2,202.9 Million by 2031, Owing to Rising Government Support Leading to Increase in Plant Tissue Culture Labs

Plant tissue culture is a technique primarily used for growing of plant cells, tissues, and/or organs using a nutrient medium. These techniques are mainly used to produce plant clones which have desirable traits like disease resistance, good flowers, high quality seeds, etc. The time taken by this method for plant production is significantly less as compared to traditional plant growing techniques which has increased its popularity considerably. There are many types of plant tissue cultures such as seed culture, embryo culture, organ culture, etc.

Forecast Analysis of the Plant Tissue Culture Market

In recent years, there has been increase in the governmental support for plant tissue culture techniques which has led to a growth in the number of plant tissue culture labs. This growth is predicted to be the primary growth driver of the plant tissue culture market in the forecast period. Additionally, growing adoption of tissue culture techniques by farmers to produce high-quality, disease-free plants is anticipated to push the market forward. Along with this, increased governmental efforts to promote sustainable agriculture and increase food production is projected to offer numerous growth and investment opportunities to the market in the analysis timeframe. However, limited production capacity over plant tissue culture is estimated to create hurdles in the full-fledged growth of the plant tissue culture market in the coming period.

Regionally, the plant tissue culture market in the Asia-Pacific region is expected to be the most dominant by 2031. Growing demand for food and high-quality ornamental plants is expected to be the leading factor behind the growth of the market in this region.

According to the report published by Research Dive, the global plant tissue culture market is expected to gather a revenue of $2,202.9 million by 2031 and grow at 6.4% CAGR in the 2022–2031 timeframe. Some prominent market players include Alpha Laboratories, Australis Capital Inc., Phytoclone Inc., Agriforest Bio-Technologies, Labland Biotech Private Limited, Rubi Bio LLC, Booms Pharm, Phytotech Laboratories, Inc., Merck KGaA, Caisson Laboratories, Inc., and many others.

Covid-19 Impact on the Market

The outbreak of the Covid-19 pandemic has had a massive negative effect on almost all industries and businesses across the world. The plant tissue culture market, however, faced a moderate impact of the pandemic. The pandemic saw a huge demand from people across the globe for plant-based products to boost their immunity which led to growth in demand for plant tissue culture. One the other hand, however, disruptions in global supply chains hampered the production and distribution channels which negatively impacted the market growth.

Significant Market Developments

The significant companies operating in the industry are adopting numerous growth strategies & business tactics such as partnerships, collaborations, mergers & acquisitions, and launches to maintain a robust position in the overall market, thus helping the plant tissue culture market to flourish. For instance:

In August 2021, ForemostCo Inc., a leading plant nursery in the US, announced that it was partnering with Vita Farms, a leading plant cuttings provider in the US, Europe, and Canada. This partnership is aimed at establishing tissue culture labs in Guatemala in order to address the supply-demand mismatches and gaps. The partnership is anticipated to help both the companies to expand their footprint in the plant tissue culture market.

In March 2022, AgriFORCE Growing Systems, a leading agriculture technology company, announced the acquisition of Deroose Plants NV, a global leader in plant tissue culture techniques. This acquisition is predicted to help the acquiring company to place itself among the major market players of the industry in the next few years.

In May 2022, Segra International Corp, a leading cannabis agriculture technology company, announced that it was partnering with Compound Genetics, a leading cannabis brand. Under this partnership agreement, nursery stock plantlets grown using plant tissue culture will be distributed to cannabis cultivators globally. The partnership is thus, expected to help both the partners immensely in the coming period.